Xintong Wang

107 West Wenhua Road
Jinan, 250012, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Chemoradiotherapy as a pivotal therapeutic modality for inoperable intrathymic thyroid carcinoma: A case report and literature review.

Chemoradiotherapy as a pivotal therapeutic modality for inoperable intrathymic thyroid carcinoma: A case report and literature review.

Journal: Medicine
Published: April 26, 2025

Response to toripalimab combined with radiotherapy in advanced non-small cell lung cancer-not otherwise specified: A case report.

Response to toripalimab combined with radiotherapy in advanced non-small cell lung cancer-not otherwise specified: A case report.

Journal: Medicine
Published: July 30, 2021

Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.

Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.

Journal: Drug design, development and therapy
Published: April 28, 2020

ASO Author Reflections: Concurrent Selective Lymph Node Radiotherapy and S-1 Plus Cisplatin for Esophageal Squamous Cell Carcinoma.

ASO Author Reflections: Concurrent Selective Lymph Node Radiotherapy and S-1 Plus Cisplatin for Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology
Published: August 29, 2019

Extracellular Hsp90α clinically correlates with tumor malignancy and promotes migration and invasion in esophageal squamous cell carcinoma.

Extracellular Hsp90α clinically correlates with tumor malignancy and promotes migration and invasion in esophageal squamous cell carcinoma.

Journal: OncoTargets and therapy
Published: February 28, 2019

MicroRNA-27a downregulates the expression of Hsp90 and enhances the radiosensitivity in esophageal squamous cell carcinoma.

MicroRNA-27a downregulates the expression of Hsp90 and enhances the radiosensitivity in esophageal squamous cell carcinoma.

Journal: OncoTargets and therapy
Published: December 07, 2018

Concurrent Selective Lymph Node Radiotherapy and S-1 Plus Cisplatin for Esophageal Squamous Cell Carcinoma: A Phase II Study.

Concurrent Selective Lymph Node Radiotherapy and S-1 Plus Cisplatin for Esophageal Squamous Cell Carcinoma: A Phase II Study.

Journal: Annals of surgical oncology
Published: October 11, 2018

The clinical significance of isocitrate dehydrogenase 2 in esophageal squamous cell carcinoma.

The clinical significance of isocitrate dehydrogenase 2 in esophageal squamous cell carcinoma.

Journal: American journal of cancer research
Published: November 09, 2016

Notch2 as a promising prognostic biomarker for oesophageal squamous cell carcinoma.

Notch2 as a promising prognostic biomarker for oesophageal squamous cell carcinoma.

Journal: Scientific reports
Published: October 21, 2015

Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.

Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.

Journal: British journal of cancer
Published: September 26, 2015

The effect of socioeconomic status on health-care delay and treatment of esophageal cancer.

The effect of socioeconomic status on health-care delay and treatment of esophageal cancer.

Journal: Journal of translational medicine
Published: October 29, 2014

Prognostic significance of lymph node ratio in esophageal cancer.

Prognostic significance of lymph node ratio in esophageal cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: October 16, 2014
Showing 1-12 of 12

Last Updated: 09/26/2026